Synbiotic-driven modulation of the gut microbiota and metabolic functions related to obesity: insights from a human gastrointestinal model - Mok, Kevin; Tomtong, Putsawee; Ogawa, Takuma; Nagai, Kenshiro; Torrungruang, Pitchsupang; Charoensiddhi, Suvimol; Nakayama, Jiro; Wanikorn, Bandhita; Nitisinprasert, Sunee; Vongsangnak, Wanwipa; Nakphaichit, Massalin (BMC microbiology, 2025)
Keywords: Adult; Bacteria; Bacteria - classification; Bacteria - genetics; Bacteria - isolation & purification; Bacteria - metabolism; Bile acids; Body weight; Care and treatment; Cholesterol; Colon; Community composition; Complications and side effects; Composition; Cresols; Culture; Development and progression; Dietary supplements; Digestive system; Dosage and administration; Feces; Feces - microbiology; Female; Fermentation; Gastrointestinal Microbiome; Gastrointestinal tract; Gastrointestinal Tract - metabolism; Gastrointestinal Tract - microbiology; Gut microbiota; Humans; In vitro gastrointestinal model; Inflammation; Intestinal microflora; Laboratories; Lactic acid; Lactic acid bacteria; Limosilactobacillus reuteri - growth & development; Limosilactobacillus reuteri KUB-AC5; Lipid metabolism; Lipids; Male; Medical research; Medicine, Experimental; Metabolic diseases; Metabolism; Metabolites; Metagenomics; Microbial Viability; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Nitrogen; Obesity; Obesity - metabolism; Obesity - microbiology; Physiological aspects; Prebiotics; Probiotics; Small intestine; Statistical analysis; Synbiotic; Synbiotics - administration & dosage; Wolffia globosa; Thailand; California; United States; Massachusetts; Germany; Gut microbiota; Obesity; In vitro gastrointestinal model; Synbiotic; Wolffia globosa; Limosilactobacillus reuteri KUB-AC5